Markus started his career in the biotechnical laboratories of Biomin, Austria as Lab technician in the R&D department. He was responsible for fermentation and QC processes of the products. After more than 4 years he decided to attend University of Applied Science to study of medical and pharmaceutical biotechnology at the IMC Krems. For his Master thesis Markus went to the Netherlands and studied the effect of the TRIAL-ligand in combination with Bortezomib on NSCLC. He joined Vela laboratories 2008. His current position is Head of Laboratory and is also heading the department of Assay Development.